The role of correction of metabolic disorders in the treatment of androgenetic alopecia in women

Yu. N Perlamutrov , M. B Antsiferov , Natalia V. Levina

Russian Journal of Skin and Venereal Diseases ›› 2016, Vol. 19 ›› Issue (5) : 300 -304.

PDF
Russian Journal of Skin and Venereal Diseases ›› 2016, Vol. 19 ›› Issue (5) : 300 -304. DOI: 10.18821/1560-9588-2016-19-5-300-304
Articles
research-article

The role of correction of metabolic disorders in the treatment of androgenetic alopecia in women

Author information +
History +
PDF

Abstract

The problem of androgenetic alopecia in women is considered by experts of various specialties, however there are few reviews about metabolic processes in these patients. Objective: to increase the efficiency of treatment of androgenetic alopecia in view of metabolic abnormalities. Material and methods. 80 female patients with androgenetic alopecia were examined to identify the features of the clinical course and hormonal metabolic deviations. Results. It was found that women with the androgenetic alopecia have abnormalities in carbohydrate and lipid metabolism in the majority of cases. Combined therapy with metformin helped to increase the clinical efficacy in the treatment of women with androgenetic alopecia.

Keywords

androgenetic alopecia / hormonal metabolic abnormalities / complex therapy / metformin / high efficiency

Cite this article

Download citation ▾
Yu. N Perlamutrov, M. B Antsiferov, Natalia V. Levina. The role of correction of metabolic disorders in the treatment of androgenetic alopecia in women. Russian Journal of Skin and Venereal Diseases, 2016, 19(5): 300-304 DOI:10.18821/1560-9588-2016-19-5-300-304

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Адаскевич В.П., Мяделец О.Д., Тихоновская И.В. Алопеция. М.: Медицинская книга; Н. Новгород: НГМА; 2000.

[2]

Гаджигороева А.Г. Клиническая трихология. М.: Практическая медицина; 2014.

[3]

Самцов А.В., Божченко А.А. Патогенез андрогенетической алопеции: современное состояние проблемы. Русский медицинский журнал. 2006; 14 (15, вып. 267): 1141-4.

[4]

Chen W., Yang C.C., Todorova A., Al Khuzaei S., Chiu H.C., Worret W.I., Ring J. Hair loss in elderly women. Eur. J. Dermatol. 2010; 20(2): 145-51. doi:10.1684/ejd.2010.0828.

[5]

Olsen EA. Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss. J. Am. Acad. Dermatol. 2003; 48(2): 253-262.

[6]

Guarrera M., Rebora A. Kenogen in female androgenetic alopecia. A longitudinal study. Dermatology. 2005; 210(1): 18-20.

[7]

Bakry O.A., Shoeib M.A., El Shafiee M.K. Hassan A. Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study. Indian Dermatol. Online J. 2014; 5(3): 276-81. doi: 10.4103/2229-5178.137776.

[8]

Cousen P., Messenger A. Female pattern hair loss in complete androgen in sensitivity syndrome. Br. J. Dermatol. 2010; 162(5): 1135-7. doi: 10.1111/j.1365-2133.2010.09661.x.

[9]

Trost L.B., Bergfeld W.F., Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J. Am. Acad. Dermatol. 2006; 54(5): 824-44.

[10]

Голоусенко И.Ю., Перламутров Ю.Н. Терапия акне у женщин с яичниковой гиперандрогенией и инсулинорезистентностью. Вестник дерматологии и венерологии. 2013; 1: 22-7.

[11]

Herskovitz I., de Sousa I.C., Tosti A. Vellus hairs in the frontal scalp in early female pattern hair loss. Int. J. Trichol. 2013; 5(3): 118-20. doi: 10.4103/0974-7753.125601.

[12]

Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br. J. Dermatol. 1977; 97(3): 247-54.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

146

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/